Capstone Investment Advisors’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,185	Closed	-$20.6K	–	1508
2024 Q1	$20.6K	Buy	1,185 +98	+9%	+$1.7K	﹤0.01%	1280
2023 Q4	$17K	Buy	+1,087	New	+$17K	﹤0.01%	1032